[HTML][HTML] Human organoids-on-chips for biomedical research and applications
Human organoids-on-chips (OrgOCs) are the synergism of human organoids (HOs)
technology and microfluidic organs-on-chips (OOCs). OOCs can mimic extrinsic …
technology and microfluidic organs-on-chips (OOCs). OOCs can mimic extrinsic …
[HTML][HTML] Microfluidic strategies for biomimetic lung chip establishment and SARS-CoV2 study
H Wang, T Wen, W Zhu, K Li, X Gong, Z Li - Materials Today Bio, 2023 - Elsevier
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV2), characterized by its high
fatality rate and contagious nature, has led to significant morbidity and mortality worldwide …
fatality rate and contagious nature, has led to significant morbidity and mortality worldwide …
[HTML][HTML] Durability of Humoral Responses after an Adapted SARS-CoV-2 mRNA Vaccine Dose in Hemodialysis Patients
We recently showed that an adapted SARS-CoV-2 vaccine with wildtype and BA. 4/BA. 5
Omicron subtype epitopes induced a broad short-term immune response in hemodialysis …
Omicron subtype epitopes induced a broad short-term immune response in hemodialysis …
Characteristics and Prognostic Factors of SARS-CoV-2 Omicron Variant Infection in Hemodialysis Patients: A Single-Center Study in China
F Zhang, G Li, J Yu, Y Shen, Y Yang, S Fu, K Liu… - Blood …, 2024 - karger.com
Introduction: This study aimed to evaluate the characteristics and prognostic factors for
coronavirus disease 2019 (COVID-19) patients on maintenance hemodialysis (HD) …
coronavirus disease 2019 (COVID-19) patients on maintenance hemodialysis (HD) …
Different vaccine platforms result in distinct antibody responses to the same antigen in haemodialysis patients
N Wall, R Lamerton, F Ashford, M Perez-Toledo… - bioRxiv, 2024 - biorxiv.org
Generalised immune dysfunction in chronic kidney disease, especially in patients requiring
haemodialysis (HD), significantly enhances the risk of severe infections. Moreover, vaccine …
haemodialysis (HD), significantly enhances the risk of severe infections. Moreover, vaccine …
Systematic Review and Meta-Analysis of the Impact of COVID-19 on Dialysis Outcomes
M Alsultan, J Boubaid, N Boobaid… - Archives of Pharmacy …, 2024 - archivepp.com
Concerns have been raised regarding the impact of COVID-19, which is produced by the
SARS-CoV-2 virus, on vulnerable groups, such as those receiving continuous dialysis for …
SARS-CoV-2 virus, on vulnerable groups, such as those receiving continuous dialysis for …
[PDF][PDF] Materials Today Bio
Z Wang, C Sun, H Wu, J Xie, T Zhang, Y Li, X Xu… - 2022 - scienceopen.com
Pulmonary drug delivery has the advantages of being rapid, efficient, and well-targeted, with
few systemic side effects. In addition, it is non-invasive and has good patient compliance …
few systemic side effects. In addition, it is non-invasive and has good patient compliance …